Bullisch
$1.10
Szenariopreis
$0.284
-0.015 (-5.43%)Zum Schluss
SmartKem, Inc. provides disruptive organic thin-film transistors, which have the potential to drive the displays. The Company’s patented TRUFLEX semiconductor and dielectric inks, or electronic polymers, are used to make transistors. Its inks enable low temperature printing processes, which are compatible with existing manufacturing infrastructure to deliver displays. Its semiconductor platform is used in various display technologies, including micro-light-emitting diode (MicroLED), LCD and AMOLED, as well as in applications in advanced computer and artificial intelligence (AI) chip packaging, sensors, and logic. The Company designs and develops its materials at its research and development facility in Manchester, the United Kingdom and provides prototyping services at the Centre for Process Innovation (CPI) in Sedgefield, the United Kingdom. The Company has an intellectual property portfolio, including 140 granted patents across 17 patent families and 40 codified trade secrets.
SmartKem Inc is not a good buy right now due to its extremely low current price of $0.30, a year-to-date decline of 99.50%, and a concerning RSI of 29.804 indicating oversold conditions. The company has faced significant financial challenges, with a net income loss of $19,369,000 in the most recent quarter and a gross margin that has fluctuated dramatically, dropping to 0% in Q2 2026. The main risk is the potential for further declines in share value, especially given the recent news of plans to issue 146.8 million common shares, which could dilute existing shareholder value.
Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

Smartkem Appoints New COO Amid Merger Plans

SRx Health Solutions and EMJ Crypto Announce Merger Agreement

SRx Health Solutions and EMJ Crypto Enter Definitive Merger Agreement

SMARTKEM INC PLANS TO ISSUE AND SELL AS MANY AS 146.8 MILLION COMMON SHARES TO KEYSTONE CAPITAL PARTNERS, ACCORDING TO SEC FILING

Veeva Systems Reports Strong Q4 Results and Raises FY27 Guidance
SmartKem, Inc. provides disruptive organic thin-film transistors, which have the potential to drive the displays. The Company’s patented TRUFLEX semiconductor and dielectric inks, or electronic polymers, are used to make transistors. Its inks enable low temperature printing processes, which are compatible with existing manufacturing infrastructure to deliver displays. Its semiconductor platform is used in various display technologies, including micro-light-emitting diode (MicroLED), LCD and AMOLED, as well as in applications in advanced computer and artificial intelligence (AI) chip packaging, sensors, and logic. The Company designs and develops its materials at its research and development facility in Manchester, the United Kingdom and provides prototyping services at the Centre for Process Innovation (CPI) in Sedgefield, the United Kingdom. The Company has an intellectual property portfolio, including 140 granted patents across 17 patent families and 40 codified trade secrets. It operates in the Technology sector (SEMICONDUCTORS AND RELATED DEVICES industry).
SmartKem Inc is not a good buy right now due to its extremely low current price of $0.30, a year-to-date decline of 99.50%, and a concerning RSI of 29.804 indicating oversold conditions. The company has faced significant financial challenges, with a net income loss of $19,369,000 in the most recent quarter and a gross margin that has fluctuated dramatically, dropping to 0% in Q2 2026. The main risk is the potential for further declines in share value, especially given the recent news of plans to issue 146.8 million common shares, which could dilute existing shareholder value.
Noch keine Beiträge
Registriere dich oder melde dich an, um mitzudiskutierenDiese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.